DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Methemoglobinemia and hemolytic anemia after rasburicase administration in a child with leukemia.

Author(s): Bauters T, Mondelaers V, Robays H, De Wilde H, Benoit Y, De Moerloose B

Affiliation(s): Department of Pharmacy, Ghent University Hospital, -1 K12, De Pintelaan 185, 9000 Ghent, Belgium. tiene.bauters@uzgent.be

Publication date & source: 2011-02, Int J Clin Pharm., 33(1):58-60. Epub 2011 Feb 4.

Publication type: Case Reports

CASE: We report a case of simultaneous methemoglobinemia and hemolytic anemia, probably related to the use of rasburicase, in a child starting treatment for acute lymphoblastic leukemia (ALL). In addition, the patient developed symptoms of pancreatitis. All complications resolved after 3 days of supportive therapy. CONCLUSION: Although usually well tolerated in pediatrics, physicians prescribing rasburicase should be aware of these possible life-threatening adverse reactions.

Page last updated: 2011-12-09

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017